NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13/01/2021
Voltar para busca
Dado oficial do USPTO
AGMASET
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
13/01/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
24/12/2010
Data de registro
19/07/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/01/2021
Última transação
13/01/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
01/12/2010
Primeiro uso no comércio
01/12/2010
Código do desenho
4
Tipo de titular
01
Localização do titular
Henderson, NV
Examinador
POVARCHUK, REBECCA
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
G. M. (pessoa física)
G. M. (pessoa física)
G. V. (pessoa física)
G. V. (pessoa física)
Representantes
GAD M. GILAD, PhD
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Antidiabetic preparations; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary drink mix for use as a meal replacement; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for aiding nerve health; Feed supplements for petslivestock; Food supplements; Food supplements for aiding nerve health; Foods for individuals with special dietary requirements necessitated by medical treatments; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Medicated supplements for foodstuffs for animals; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for aiding nerve health; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional additives for medical purposes used in foods and dietary supplements for human consumption; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements; Nutritional supplements for aiding nerve health; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Ophthalmic preparations; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention of nervous system damage; Pharmaceutical preparations for the treatment and prevention of nervous system damage; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of nervous system damage; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for nervous system damage; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsantidepressants; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Powdered nutritional supplement drink mix; Preparation for the relief of pain; Therapeutic pharmaceutical for the treatment of nervous system damage; Veterinary preparations for nervous system damage; Veterinary preparationspain relief medication; Vitamins and dietary food supplements for animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
20/10/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
19/07/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28/09/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28/09/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/09/2016
E815
TEAS SECTION 8 & 15 RECEIVED
24/07/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/07/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/07/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
19/07/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2011
PUBO
PUBLISHED FOR OPPOSITION
03/05/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/03/2011
DOCK
ASSIGNED TO EXAMINER
23/03/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2011
NWAP
NEW APPLICATION ENTERED
28/12/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AGMASET ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.